1. Home
  2. CELU vs MAMK Comparison

CELU vs MAMK Comparison

Compare CELU & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MAMK
  • Stock Information
  • Founded
  • CELU 2016
  • MAMK 2007
  • Country
  • CELU United States
  • MAMK China
  • Employees
  • CELU N/A
  • MAMK N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MAMK Apparel
  • Sector
  • CELU Health Care
  • MAMK Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • MAMK Nasdaq
  • Market Cap
  • CELU 42.2M
  • MAMK 43.2M
  • IPO Year
  • CELU N/A
  • MAMK 2025
  • Fundamental
  • Price
  • CELU $3.86
  • MAMK $2.16
  • Analyst Decision
  • CELU Buy
  • MAMK
  • Analyst Count
  • CELU 1
  • MAMK 0
  • Target Price
  • CELU $6.00
  • MAMK N/A
  • AVG Volume (30 Days)
  • CELU 66.2K
  • MAMK 92.8K
  • Earning Date
  • CELU 10-15-2025
  • MAMK 01-01-0001
  • Dividend Yield
  • CELU N/A
  • MAMK N/A
  • EPS Growth
  • CELU N/A
  • MAMK N/A
  • EPS
  • CELU N/A
  • MAMK 0.12
  • Revenue
  • CELU $44,590,000.00
  • MAMK $21,434,100.00
  • Revenue This Year
  • CELU $23.29
  • MAMK N/A
  • Revenue Next Year
  • CELU N/A
  • MAMK N/A
  • P/E Ratio
  • CELU N/A
  • MAMK $17.87
  • Revenue Growth
  • CELU 138.11
  • MAMK N/A
  • 52 Week Low
  • CELU $1.00
  • MAMK $1.87
  • 52 Week High
  • CELU $5.22
  • MAMK $4.00
  • Technical
  • Relative Strength Index (RSI)
  • CELU 60.90
  • MAMK N/A
  • Support Level
  • CELU $3.52
  • MAMK N/A
  • Resistance Level
  • CELU $4.01
  • MAMK N/A
  • Average True Range (ATR)
  • CELU 0.34
  • MAMK 0.00
  • MACD
  • CELU -0.01
  • MAMK 0.00
  • Stochastic Oscillator
  • CELU 64.84
  • MAMK 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About MAMK MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.

Share on Social Networks: